Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada
- PMID: 38455876
- PMCID: PMC10917133
- DOI: 10.14745/ccdr.v49i78a01
Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada
Abstract
Background: Enteric infections and their chronic sequelae are a major cause of disability and death. Despite the increasing use of administrative health data in measuring the burden of chronic diseases in the population, there is a lack of validated International Classification of Disease (ICD) code-based case definitions, particularly in the Canadian context. Our objective was to validate ICD code definitions for sequelae of enteric infections in Canada: acute kidney injury (AKI); hemolytic uremic syndrome (HUS); thrombotic thrombocytopenic purpura (TTP); Guillain-Barré syndrome/Miller-Fisher syndrome (GBS/MFS); chronic inflammatory demyelinating polyneuropathy (CIDP); ankylosing spondylitis (AS); reactive arthritis; anterior uveitis; Crohn's disease, ulcerative colitis, celiac disease, erythema nodosum (EN); neonatal listeriosis (NL); and Graves' disease (GD).
Methods: We used a multi-step approach by conducting a literature review to identify existing validated definitions, a clinician assessment of the validated definitions, a chart review to verify proposed definitions and a final clinician review. We measured the sensitivity and positive predictive value (PPV) of proposed definitions.
Results: Forty studies met inclusion criteria. We identified validated definitions for 12 sequelae; clinicians developed three (EN, NL, GD). We reviewed 181 charts for 6 sequelae (AKI, HUS, TTP, GBS/MFS, CIDP, AS). Sensitivity (42.8%-100%) and PPV (63.6%-100%) of ICD code definitions varied. Six definitions were modified by clinicians following the chart review (AKI, TTP, GBS/MFS, CIDP, AS, reactive arthritis) to reflect coding practices, increase specificity or sensitivity, and address logistical constraints.
Conclusion: The multi-step design to derive ICD code definitions provided flexibility to identify existing definitions, to improve their sensitivity and PPV and adapt them to the Canadian context.
Keywords: administrative data; case definition; enteric infections; sequelae.
Conflict of interest statement
Competing interests Ethics approval was received from the University of British Columbia Clinical Review Ethics Board (H18-01664). EG and SEM report funding for this study as per the funding statement. At the time of the study, EG’s spouse worked for an electronic medical records’ company; this interest was not related to, or used in, this study. SEM reports other relationships though these interests were not used in this study: she has served as a paid expert on behalf of the Attorney General of Canada in legal proceedings, providing evidence on the public health risks and benefits of unpasteurised milk; she is an expert on the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts; she is a Member of the WHO Foodborne Disease Burden Epidemiology Reference Group. GK reports honoraria for speaking from AbbVie, Janssen, Pfizer, Amgen, Sandoz, and Pendophram; research support from Ferring; shared ownership of a patent: treatment of inflammatory disorders, autoimmune disease, and PBC. UTI Limited Partnership, assignee. Patent WO2019046959A1. PCT/CA2018/051098. 7 Sept. 2018; these interests were not related to, or used in, this study. JC reports research support from Pfizer and UCB for unrelated research; advisory board consulting fees from Abbvie, Organon, UCB, Novartis, Eli Lilly, Sandoz, Jansen, Pfizer, Roche, Merck, Viatris, and Fresenius Kabi; paid lectures from Eli Lilly, Viatris, Abbvie, Pfizer, Novartis, Fresenius Kabi, and UCB; support for attending ACR 2021 meeting from Jansen; unpaid leadership roles at Spondyloarthritis Research Consortium of Canada, Spondyloarthritis Research and Treatment Network, Group for Research and Assessment of Psoriasis and Psoriatic arthritis, and Assessment of Spondyloarthritis International Society; these interests were not related to, or used in, this study. KC reports board membership at CIDP Foundation of Canada, though this interest was not related to this study. All other authors declare no competing interests.
Similar articles
-
Validating ICD-10 Diagnosis Codes for Guillain-Barré Syndrome in Taiwan's National Health Insurance Claims Database.Clin Epidemiol. 2024 Oct 21;16:733-742. doi: 10.2147/CLEP.S485953. eCollection 2024. Clin Epidemiol. 2024. PMID: 39445227 Free PMC article.
-
Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates.Health Serv Res. 2013 Feb;48(1):290-318. doi: 10.1111/j.1475-6773.2012.01440.x. Epub 2012 Jun 28. Health Serv Res. 2013. PMID: 22742621 Free PMC article.
-
Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.Neurol Neuroimmunol Neuroinflamm. 2021 Jun 17;8(5):e1031. doi: 10.1212/NXI.0000000000001031. Print 2021 Jul. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34140310 Free PMC article.
-
A Systematic Review of Crohn's Disease Case Definitions in Administrative or Claims Databases.Inflamm Bowel Dis. 2023 May 2;29(5):705-715. doi: 10.1093/ibd/izac131. Inflamm Bowel Dis. 2023. PMID: 35857336 Free PMC article.
-
[Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].Rev Neurol. 2002 Aug 1-15;35(3):269-76. Rev Neurol. 2002. PMID: 12235589 Review. Spanish.
Cited by
-
Validating ICD-10 Diagnosis Codes for Guillain-Barré Syndrome in Taiwan's National Health Insurance Claims Database.Clin Epidemiol. 2024 Oct 21;16:733-742. doi: 10.2147/CLEP.S485953. eCollection 2024. Clin Epidemiol. 2024. PMID: 39445227 Free PMC article.
References
-
- Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ, Praet N, Bellinger DC, de Silva NR, Gargouri N, Speybroeck N, Cawthorne A, Mathers C, Stein C, Angulo FJ, Devleesschauwer B, Devleesschauwer B; World Health Organization Foodborne Disease Burden Epidemiology Reference Group . World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLoS Med 2015;12(12):e1001923. 10.1371/journal.pmed.1001923 - DOI - PMC - PubMed
-
- Thomas MK, Murray R, Flockhart L, Pintar K, Fazil A, Nesbitt A, Marshall B, Tataryn J, Pollari F. Estimates of foodborne illness-related hospitalizations and deaths in Canada for 30 specified pathogens and unspecified agents. Foodborne Pathog Dis 2015;12(10):820–7. 10.1089/fpd.2015.1966 - DOI - PMC - PubMed
-
- Gould LH, Demma L, Jones TF, Hurd S, Vugia DJ, Smith K, Shiferaw B, Segler S, Palmer A, Zansky S, Griffin PM. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009;49(10):1480–5. 10.1086/644621 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous